EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 254 filers reported holding EXELIXIS INC in Q2 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $240,000 | -70.3% | 11,051 | -79.6% | 0.01% | -52.6% |
| Q4 2016 | $807,000 | -29.6% | 54,100 | -39.6% | 0.02% | -20.8% |
| Q3 2016 | $1,146,000 | -14.0% | 89,600 | -47.5% | 0.02% | +4.3% |
| Q2 2016 | $1,332,000 | +255.2% | 170,600 | +82.4% | 0.02% | +228.6% |
| Q1 2016 | $375,000 | -39.8% | 93,537 | -15.3% | 0.01% | +16.7% |
| Q4 2015 | $623,000 | +83.2% | 110,400 | +82.2% | 0.01% | +100.0% |
| Q3 2015 | $340,000 | +157.6% | 60,600 | +72.6% | 0.00% | +200.0% |
| Q2 2015 | $132,000 | -30.9% | 35,100 | -52.7% | 0.00% | -50.0% |
| Q1 2015 | $191,000 | +130.1% | 74,200 | +29.5% | 0.00% | +100.0% |
| Q4 2014 | $83,000 | -48.1% | 57,311 | -45.5% | 0.00% | 0.0% |
| Q3 2014 | $160,000 | -60.5% | 105,100 | -11.9% | 0.00% | -50.0% |
| Q2 2014 | $405,000 | +185.2% | 119,331 | +198.3% | 0.00% | +100.0% |
| Q1 2014 | $142,000 | +79.7% | 40,000 | +211.2% | 0.00% | – |
| Q4 2013 | $79,000 | -2.5% | 12,854 | -7.9% | 0.00% | -100.0% |
| Q3 2013 | $81,000 | +62.0% | 13,954 | +25.6% | 0.00% | – |
| Q2 2013 | $50,000 | – | 11,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |